Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Die Folgen des Klimwandels haben einen direkten Einfluss auf die Primärversorgung in Deutschland: Hitzeschutz insbesondere bei älteren Patienten, die Zunahme von Infektionen und die Verlängerung der Allergiesesaison spielen medizinisch eine bedeutsame Rolle. Aber auch in der Prävention und der Aufklärung der Patienten kommt den Hausärztinnen und -ärzten eine besondere Rolle zu. Direkt aus der Praxis berichtet im Live-Webinar am 13. Mai von 18 bis 19 Uhr unser Experte Dr. med. Robin Maitra.
Erweiterte Suche
Anmelden
nach oben
European Child & Adolescent Psychiatry
Erschienen in: European Child & Adolescent Psychiatry 9/2017

13.03.2017 | Review

Gut microbiota and attention deficit hyperactivity disorder: new perspectives for a challenging condition

verfasst von: María Carmen Cenit, Isabel Campillo Nuevo, Pilar Codoñer-Franch, Timothy G. Dinan, Yolanda Sanz

Erschienen in: European Child & Adolescent Psychiatry | Ausgabe 9/2017

Einloggen, um Zugang zu erhalten

Abstract

A bidirectional communication between the gut and the brain (gut–brain axis) is well recognized with the gut microbiota viewed as a key regulator of this cross-talk. Currently, a body of preclinical and to a lesser extent epidemiological evidence supports the notion that host–microbe interactions play a key role in brain development and function and in the etiology of neurodevelopmental disorders. Early life events and shifts away from traditional lifestyles are known to impact gut microbiota composition and function and, thereby, may increase the risk of developing neurodevelopmental disorders. Attention deficit hyperactivity disorder (ADHD) is nowadays the most prevalent neurodevelopmental disorder. Despite many years of research its etiology is unclear and its diagnosis and treatment are still challenging. Different factors reported to be associated with the risk of developing ADHD and/or linked to different ADHD manifestations have also been linked to shifts in gut microbiota composition, suggesting a link between the microbiota and the disorder. Evidence from preliminary human studies also suggests that dietary components that modulate gut microbiota may also influence ADHD development or symptoms, although further studies are warranted to confirm this hypothesis. Here, we firstly review the potential mechanisms by which the gut microbiota may regulate the brain–gut axis and influence behavior and neurodevelopmental disorders. Secondly, we discuss the current knowledge about the different factors and dietary components reported to be associated with the risk of developing ADHD or its manifestations and with shifts in gut microbiota composition. Finally, we briefly highlight the need to progress our understanding regarding the role of the gut microbiota in ADHD, since this could open new avenues for early intervention and improved management of the disease.
Literatur
1.
Martens G, van Loo K (2007) Genetic and environmental factors in complex neurodevelopmental disorders. Curr Genom 8:429–444CrossRef
2.
Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA (2007) The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 164:942–948PubMedCrossRef
3.
Kooij SJJ et al (2010) European consensus statement on diagnosis and treatment of adult ADHD: the European network adult ADHD. BMC Psychiatry 10:67PubMedPubMedCentralCrossRef
4.
Trull TJ, Tragesser SL, Solhan M, Schwartz-Mette R (2007) Dimensional models of personality disorder: diagnostic and statistical manual of mental disorders fifth edition and beyond. Curr Opin Psychiatry 20:52–56PubMedCrossRef
5.
Larson K, Russ SA, Kahn RS, Halfon N (2011) Patterns of comorbidity, functioning, and service use for US children with ADHD, 2007. Pediatrics 127:462–470PubMedPubMedCentralCrossRef
6.
Dias TGC et al (2013) Developments and challenges in the diagnosis and treatment of ADHD. Rev Bras Psiquiatr 35:S40–S50PubMedCrossRef
7.
Childress AC, Sallee FR (2014) Attention-deficit/hyperactivity disorder with inadequate response to stimulants: approaches to management. CNS Drugs 28:121–129PubMedCrossRef
8.
Shyu Y-C et al (2015) Attention-deficit/hyperactivity disorder, methylphenidate use and the risk of developing schizophrenia spectrum disorders: a nationwide population-based study in Taiwan. Schizophr Res 168:161–167PubMedCrossRef
9.
Martinez-Raga J, Knecht C, Szerman N, Martinez MI (2013) Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder. CNS Drugs 27:15–30PubMedCrossRef
10.
Sprich S, Biederman J, Crawford MH, Mundy E, Faraone SV (2000) Adoptive and biological families of children and adolescents with ADHD. J Am Acad Child Adolesc Psychiatry 39:1432–1437PubMedCrossRef
11.
Thapar A, Cooper M, Eyre O, Langley K (2013) Practitioner review: what have we learnt about the causes of ADHD? J Child Psychol Psychiatry 54:3–16PubMedPubMedCentralCrossRef
12.
Sharma A, Couture J (2014) A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD). Ann Pharmacother 48:209–225PubMedCrossRef
13.
Banaschewski T, Becker K, Scherag S, Franke B, Coghill D (2010) Molecular genetics of attention-deficit/hyperactivity disorder: an overview. Eur Child Adolesc Psychiatry 19:237–257PubMedPubMedCentralCrossRef
14.
Dinan TG, Cryan JF (2015) The impact of gut microbiota on brain and behaviour: implications for psychiatry. Curr Opin Clin Nutr Metab Care 18:552–558PubMedCrossRef
15.
16.
Cryan JF, Dinan TG (2012) Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 13:701–712PubMedCrossRef
17.
18.
Luczynski P et al (2016) Growing up in a bubble: using germ-free animals to assess the influence of the gut microbiota on brain and behavior. Int J Neuropsychopharmacol. 19(8). doi:10.​1093/​ijnp/​pyw020
19.
Cryan JF, Dinan TG (2015) More than a gut feeling: the microbiota regulates neurodevelopment and behavior. Neuropsychopharmacology 40:241–242PubMedCrossRef
20.
De Palma G et al (2015) Microbiota and host determinants of behavioural phenotype in maternally separated mice. Nat Commun 6:7735PubMedCrossRef
21.
Collins SM, Kassam Z, Bercik P (2013) The adoptive transfer of behavioral phenotype via the intestinal microbiota: experimental evidence and clinical implications. Curr Opin Microbiol 16:240–245PubMedCrossRef
22.
23.
Lyte M (2011) Probiotics function mechanistically as delivery vehicles for neuroactive compounds: microbial endocrinology in the design and use of probiotics. Bioessays 33:574–581PubMedCrossRef
24.
Bercik P et al (2011) The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 141:599–609 (609.e1–3) PubMedCrossRef
25.
Collins SM, Bercik P (2009) The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology 136:2003–2014PubMedCrossRef
26.
Barrett E, Ross RP, O’Toole PW, Fitzgerald GF, Stanton C (2012) γ-Aminobutyric acid production by culturable bacteria from the human intestine. J Appl Microbiol 113:411–417PubMedCrossRef
27.
Dinan TG, Stanton C, Cryan JF (2013) Psychobiotics: a novel class of psychotropic. Biol Psychiatry 74:720–726PubMedCrossRef
28.
Clarke G et al (2012) A distinct profile of tryptophan metabolism along the kynurenine pathway downstream of toll-like receptor activation in irritable bowel syndrome. Front Pharmacol 3:90PubMedPubMedCentralCrossRef
29.
O’Mahony SM, Clarke G, Borre YE, Dinan TG, Cryan JF (2014) Serotonin, tryptophan metabolism and the brain–gut- microbiome axis. Behav Brain Res 277:32–48PubMedCrossRef
30.
Maes M, Mihaylova I, Ruyter M De, Kubera M, Bosmans E (2007) The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression—and other conditions characterized by tryptophan depletion induced by inflammation. Neuro Endocrinol Lett 28:826–831PubMed
31.
32.
33.
Clarke G et al (2013) The microbiome-gut–brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry 18:666–673PubMedCrossRef
34.
Desbonnet L, Garrett L, Clarke G, Bienenstock J, Dinan TG (2008) The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat. J Psychiatr Res 43:164–174PubMedCrossRef
35.
Foley KA, MacFabe DF, Vaz A, Ossenkopp K-P, Kavaliers M (2014) Sexually dimorphic effects of prenatal exposure to propionic acid and lipopolysaccharide on social behavior in neonatal, adolescent, and adult rats: implications for autism spectrum disorders. Int J Dev Neurosci 39:68–78PubMedCrossRef
36.
MacFabe DF et al (2007) Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behav Brain Res 176:149–169PubMedCrossRef
37.
Stilling RM, Dinan TG, Cryan JF (2014) Microbial genes, brain and behaviour-epigenetic regulation of the gut–brain axis. Genes Brain Behav 13:69–86PubMedCrossRef
38.
39.
Corominas-Roso M et al (2013) Decreased serum levels of brain-derived neurotrophic factor in adults with attention-deficit hyperactivity disorder. Int J Neuropsychopharmacol 1–9. doi:10.​1017/​S146114571200162​9
40.
41.
Rodriguez A, Bohlin G (2005) Are maternal smoking and stress during pregnancy related to ADHD symptoms in children? J Child Psychol Psychiatry 46:246–254PubMedCrossRef
42.
Zijlmans MAC, Korpela K, Riksen-Walraven JM, de Vos WM, de Weerth C (2015) Maternal prenatal stress is associated with the infant intestinal microbiota. Psychoneuroendocrinology 53:233–245PubMedCrossRef
43.
Barrett E et al (2013) The individual-specific and diverse nature of the preterm infant microbiota. Arch Dis Child Fetal Neonatal Ed 98:F334–F340PubMedCrossRef
44.
Jakobsson HE et al (2014) Decreased gut microbiota diversity, delayed bacteroidetes colonisation and reduced Th1 responses in infants delivered by caesarean section. Gut 63:559–566PubMedCrossRef
45.
Grönlund MM, Lehtonen OP, Eerola E, Kero P (1999) Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery. J Pediatr Gastroenterol Nutr 28:19–25PubMedCrossRef
46.
Dominguez-Bello MG et al (2010) Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA 107:11971–11975PubMedPubMedCentralCrossRef
47.
Boksa P, El-Khodor BF (2003) Birth insult interacts with stress at adulthood to alter dopaminergic function in animal models: possible implications for schizophrenia and other disorders. Neurosci Biobehav Rev 27:91–101PubMedCrossRef
48.
Curran EA et al (2015) Association between obstetric mode of delivery and autism spectrum disorder: a population-based sibling design study. JAMA psychiatry 72:935–942PubMedCrossRef
49.
Curran EA et al (2015) Research review: birth by caesarean section and development of autism spectrum disorder and attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. J Child Psychol Psychiatry 56:500–508PubMedCrossRef
50.
Talge NM, Allswede DM, Holzman C (2016) Gestational age at term, delivery circumstance, and their association with childhood attention deficit hyperactivity disorder symptoms. Paediatr Perinat Epidemiol 30:171–180PubMedCrossRef
51.
Amiri S, Malek A, Sadegfard M, Abdi S (2012) Pregnancy-related maternal risk factors of attention-deficit hyperactivity disorder: a case-control study. ISRN Pediatr 2012:458064PubMedPubMedCentralCrossRef
52.
Chu S-M et al (2012) The relationship between attention deficit hyperactivity disorder and premature infants in Taiwanese: a case control study. BMC Psychiatry 12:85PubMedPubMedCentralCrossRef
53.
Johnson S et al (2016) Antecedents of attention-deficit/hyperactivity disorder symptoms in children born extremely preterm. J Dev Behav Pediatr 37:285–297PubMedPubMedCentralCrossRef
54.
55.
Sternbach H, State R (1997) Antibiotics: neuropsychiatric effects and psychotropic interactions. Harv Rev Psychiatry 5:214–226PubMedCrossRef
56.
Van den Bergh BRH, Marcoen A (2004) High antenatal maternal anxiety is related to ADHD symptoms, externalizing problems, and anxiety in 8- and 9-year-olds. Child Dev 75:1085–1097PubMedCrossRef
57.
Li J, Olsen J, Vestergaard M, Obel C (2010) Attention-deficit/hyperactivity disorder in the offspring following prenatal maternal bereavement: a nationwide follow-up study in Denmark. Eur Child Adolesc Psychiatry 19:747–753PubMedCrossRef
58.
Grizenko N, Shayan YR, Polotskaia A, Ter-Stepanian M, Joober R (2008) Relation of maternal stress during pregnancy to symptom severity and response to treatment in children with ADHD. J Psychiatry Neurosci 33:10–16PubMedPubMedCentral
59.
Culhane JF et al (2001) Maternal stress is associated with bacterial vaginosis in human pregnancy. Matern Child Health J 5:127–134PubMedCrossRef
60.
Sudo N et al (2004) Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol 558:263–275PubMedPubMedCentralCrossRef
61.
Sterley T-L, Howells FM, Russell VA (2013) Maternal separation increases GABA(A) receptor-mediated modulation of norepinephrine release in the hippocampus of a rat model of ADHD, the spontaneously hypertensive rat. Brain Res 1497:23–31PubMedCrossRef
62.
Womersley JS, Hsieh JH, Kellaway LA, Gerhardt GA, Russell VA (2011) Maternal separation affects dopamine transporter function in the spontaneously hypertensive rat: an in vivo electrochemical study. Behav Brain Funct 7:49PubMedPubMedCentralCrossRef
63.
Sanz Y (2016) Bifidobacteria in Foods: health Effects. Encycl Food Heal 1:388–394CrossRef
64.
Mann JR, McDermott S (2011) Are maternal genitourinary infection and pre-eclampsia associated with ADHD in school-aged children? J Atten Disord 15:667–673PubMedCrossRef
65.
Silva D, Colvin L, Hagemann E, Bower C (2014) Environmental risk factors by gender associated with attention-deficit/hyperactivity disorder. Pediatrics 133:e14–e22PubMedCrossRef
66.
Hsiao EY et al (2013) Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155:1451–1463PubMedPubMedCentralCrossRef
67.
68.
69.
70.
71.
Rodriguez A et al (2008) Maternal adiposity prior to pregnancy is associated with ADHD symptoms in offspring: evidence from three prospective pregnancy cohorts. Int J Obes (Lond) 32:550–557CrossRef
72.
Kang SS, Kurti A, Fair DA, Fryer JD (2014) Dietary intervention rescues maternal obesity induced behavior deficits and neuroinflammation in offspring. J Neuroinflammation 11:156PubMedPubMedCentralCrossRef
73.
Cabrera-Rubio R et al (2012) The human milk microbiome changes over lactation and is shaped by maternal weight and mode of delivery. Am J Clin Nutr 96:544–551PubMedCrossRef
74.
75.
Cani PD (2013) Gut microbiota and obesity: lessons from the microbiome. Brief Funct Genom 12:381–387CrossRef
76.
Foster JA, McVey Neufeld K-A (2013) Gut–brain axis: how the microbiome influences anxiety and depression. Trends Neurosci 36:305–312PubMedCrossRef
77.
Mimouni-Bloch A et al (2013) Breastfeeding may protect from developing attention-deficit/hyperactivity disorder. Breastfeed Med 8:363–367PubMedCrossRef
78.
79.
80.
Dash S, Clarke G, Berk M, Jacka FN (2015) The gut microbiome and diet in psychiatry: focus on depression. Curr Opin Psychiatry 28:1–6PubMedCrossRef
81.
Psaltopoulou T et al (2013) Mediterranean diet, stroke, cognitive impairment, and depression: a meta-analysis. Ann Neurol 74:580–591PubMedCrossRef
82.
Jacka FN et al (2013) Maternal and early postnatal nutrition and mental health of offspring by age 5 years: a prospective cohort study. J Am Acad Child Adolesc Psychiatry 52:1038–1047PubMedCrossRef
83.
Konikowska K, Regulska-Ilow B, Rózańska D (2012) The influence of components of diet on the symptoms of ADHD in children. Rocz Państwowego Zakładu Hig 63:127–134
84.
Pelsser LM et al (2011) Effects of a restricted elimination diet on the behaviour of children with attention-deficit hyperactivity disorder (INCA study): a randomised controlled trial. Lancet 377:494–503PubMedCrossRef
85.
Sonuga-Barke EJS et al (2013) Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry 170:275–289PubMedCrossRef
86.
Stulnig TM, Zeyda M (2004) Immunomodulation by polyunsaturated fatty acids: impact on T-cell signaling. Lipids 39:1171–1175PubMedCrossRef
87.
Kaliannan K, Wang B, Li X-Y, Kim K-J, Kang JX (2015) A host–microbiome interaction mediates the opposing effects of omega-6 and omega-3 fatty acids on metabolic endotoxemia. Sci Rep 5:11276PubMedPubMedCentralCrossRef
88.
Yu H-N et al (2014) Effects of fish oil with a high content of n-3 polyunsaturated fatty acids on mouse gut microbiota. Arch Med Res 45:195–202PubMedCrossRef
89.
90.
Hawkey E, Nigg JT (2014) Omega-3 fatty acid and ADHD: blood level analysis and meta-analytic extension of supplementation trials. Clin Psychol Rev 34:496–505PubMedPubMedCentralCrossRef
91.
Ferreira CF et al (2014) Correlation between n-3 polyunsaturated fatty acids consumption and BDNF peripheral levels in adolescents. Lipids Health Dis 13:44PubMedPubMedCentralCrossRef
92.
Howard AL et al (2011) ADHD is associated with a ‘Western’ dietary pattern in adolescents. J Atten Disord 15:403–411PubMedCrossRef
93.
Freeman MP et al (2006) Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry 67:1954–1967PubMedCrossRef
94.
Zhang X-W, Hou W-S, Li M, Tang Z-Y (2015) Omega-3 fatty acids and risk of cognitive decline in the elderly: a meta-analysis of randomized controlled trials. Aging Clin Exp Res. doi:10.​1007/​s40520-015-0381-9
95.
Letenneur L, Proust-Lima C, Le Gouge A, Dartigues JF, Barberger-Gateau P (2007) Flavonoid intake and cognitive decline over a 10-year period. Am J Epidemiol 165:1364–1371PubMedCrossRef
96.
Desideri G et al (2012) Benefits in cognitive function, blood pressure, and insulin resistance through cocoa flavanol consumption in elderly subjects with mild cognitive impairment: the cocoa, cognition, and aging (CoCoA) study. Hypertension 60:794–801PubMedCrossRef
97.
Dvoráková M et al (2007) Urinary catecholamines in children with attention deficit hyperactivity disorder (ADHD): modulation by a polyphenolic extract from pine bark (pycnogenol). Nutr Neurosci 10:151–157PubMedCrossRef
98.
Selma MV, Espín JC, Tomás-Barberán FA (2009) Interaction between phenolics and gut microbiota: role in human health. J Agric Food Chem 57:6485–6501PubMedCrossRef
99.
Duda-Chodak A, Tarko T, Satora P, Sroka P (2015) Interaction of dietary compounds, especially polyphenols, with the intestinal microbiota: a review. Eur J Nutr 54:325–341PubMedPubMedCentralCrossRef
100.
Laparra JM, Sanz Y (2010) Interactions of gut microbiota with functional food components and nutraceuticals. Pharmacol Res 61:219–225PubMedCrossRef
101.
McKeown C, Hisle-Gorman E, Eide M, Gorman GH, Nylund CM (2013) Association of constipation and fecal incontinence with attention-deficit/hyperactivity disorder. Pediatrics 132:e1210–e1215PubMedPubMedCentralCrossRef
102.
Stevens LJ, Kuczek T, Burgess JR, Hurt E, Arnold LE (2011) Dietary sensitivities and ADHD symptoms: thirty-five years of research. Clin Pediatr (Phila) 50:279–293CrossRef
103.
Pärtty A, Kalliomäki M, Wacklin P, Salminen S, Isolauri E (2015) A possible link between early probiotic intervention and the risk of neuropsychiatric disorders later in childhood: a randomized trial. Pediatr Res 77:823–828PubMedCrossRef
104.
Sekirov I, Russell SL, Antunes LCM, Finlay BB (2010) Gut microbiota in health and disease. Physiol Rev 90:859–904PubMedCrossRef
105.
Chung H, Kasper DL (2010) Microbiota-stimulated immune mechanisms to maintain gut homeostasis. Curr Opin Immunol 22:455–460PubMedCrossRef
106.
Atarashi K, Honda K (2011) Microbiota in autoimmunity and tolerance. Curr Opin Immunol 23:761–768PubMedCrossRef
107.
Verlaet AAJ, Noriega DB, Hermans N, Savelkoul HFJ (2014) Nutrition, immunological mechanisms and dietary immunomodulation in ADHD. Eur Child Adolesc Psychiatry 23:519–529PubMedCrossRef
108.
Toral M et al (2014) The probiotic Lactobacillus coryniformis CECT5711 reduces the vascular pro-oxidant and pro-inflammatory status in obese mice. Clin Sci 127:33–45PubMedCrossRef
109.
Chen L et al (2013) Lactobacillus acidophilus ATCC 4356 attenuates the atherosclerotic progression through modulation of oxidative stress and inflammatory process. Int Immunopharmacol 17:108–115PubMedCrossRef
110.
Joseph N, Zhang-James Y, Perl A, Faraone SV (2015) Oxidative stress and ADHD: a meta-analysis. J Atten Disord 19:915–924PubMedCrossRef
111.
Kul M et al (2015) Evaluation of oxidative metabolism in child and adolescent patients with attention deficit hyperactivity disorder. Psychiatry Investig 12:361–366PubMedPubMedCentralCrossRef
112.
Sezen H et al (2016) Increased oxidative stress in children with attention deficit hyperactivity disorder. Redox Rep 21:248–253PubMedCrossRef
Metadaten
Titel
Gut microbiota and attention deficit hyperactivity disorder: new perspectives for a challenging condition
verfasst von
María Carmen Cenit
Isabel Campillo Nuevo
Pilar Codoñer-Franch
Timothy G. Dinan
Yolanda Sanz
Publikationsdatum
13.03.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
European Child & Adolescent Psychiatry / Ausgabe 9/2017
Print ISSN: 1018-8827
Elektronische ISSN: 1435-165X
DOI
https://doi.org/10.1007/s00787-017-0969-z

Weitere Artikel der Ausgabe 9/2017

European Child & Adolescent Psychiatry 9/2017 Zur Ausgabe

Review

Vitamin D and mental health in children and adolescents

Original Contribution

Predicting academic impairment and internalizing psychopathology using a multidimensional framework of Sluggish Cognitive Tempo with parent- and adolescent reports

Review

Medical comorbidities in children and adolescents with autism spectrum disorders and attention deficit hyperactivity disorders: a systematic review

Review

Elimination diets’ efficacy and mechanisms in attention deficit hyperactivity disorder and autism spectrum disorder

Original Contribution

Associations between social vulnerabilities and psychosocial problems in European children. Results from the IDEFICS study

Original Contribution

Sleep problems in children with attention-deficit hyperactivity disorder: associations with parenting style and sleep hygiene

Neu im Fachgebiet Psychiatrie

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise